Robert Gil

Showing 1-9 of 9 articles

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials

Gil R, Bil J, Kern A, Ingio Garcia L, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A

March 20, 2020 | 10.4244/EIJ-D-18-00172

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study

Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00189

Coronary interventions

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R, Bil J, Grundeken M.J, Kern A, Iñigo Garcia L, Vassilev D, Pawłowski T, Formuszewicz R, Dobrzycki S, Wykrzykowska J, Serruys P

December 9, 2016 | 10.4244/EIJY15M11_11

Coronary interventions

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

Gil R, Bil J, Grundeken M.J, Iñigo Garcia L, Vassilev D, Kern A, Pawłowski T, Wykrzykowska J, Serruys P

November 20, 2016 | 10.4244/EIJY15M10_05

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA29

Coronary interventions

The BiOSS stent

Gil R, Bil J, Vassilev D

May 19, 2015 | 10.4244/EIJV11SVA37

Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population

Gil R, Vassilev D, Michalek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A

July 27, 2012 | 10.4244/EIJV8I3A50

Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model

Vassilev D, Gil R, Milewski K

September 30, 2011 | 10.4244/EIJV7I5A98

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke